Emese Bedrosian

Nurse Practitioner - Acute Care

Emese Bedrosian is a Chicago, Illinois based nurse practitioner who is specialized as Acute Care nurse. Her current practice location is 207 W Harrison St Apt 515, Chicago. Patients can reach her at 614-312-3524 with specialization in Acute Care and her NPI number (Unique professional ID assigned by NPPES) is 1417701186.
Emese Bedrosian is a licensed independent practitioner and may autonomously provide care. She provides advanced nursing care across the continuum of health care services to meet the specialized physiologic and psychological needs of patients with acute, critical, and/or complex chronic health conditions. This care is continuous and comprehensive and may be provided in any setting where the patient may be found.

Complete Profile:
Emese Bedrosian speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Emese Bedrosian
Specialization: Acute Care Nurse Practitioner (ACNP)
Gender:Female
Practice Address:207 W Harrison St Apt 515, Chicago,
Illinois, 60607-5046
Phone:614-312-3524
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1417701186
NPI Enumeration Date: 17 Apr, 2024
NPI Last Update On: 23 Aug, 2024

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Emese Bedrosian
207 W Harrison St Apt 515,
Chicago, Illinois
Zip: 60607-5046
Phone Number: 614-312-3524
Patients can reach Emese Bedrosian at 207 W Harrison St Apt 515, Chicago, Illinois or can call to book an appointment on 614-312-3524.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.